Physician profile
Cameron Darvish
NPI 1275586711
$762.56
in general payments reported to CMS, 2019-2025
13 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $26.25 · 2021: $123 · 2022: $72.79 · 2023: $163 · 2024: $111 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $240.23 | 2020-2025 | Slynd, Nuvessa, Nuvessa |
| Mayne Pharma Commercial LLC | $123.31 | 2022-2025 | |
| Astellas Pharma US INC | $88.06 | 2023-2025 | Veozah |
| Evofem Biosciences, INC. | $85.23 | 2021-2025 | Solosec, Phexx, Phexxi |
| Coopersurgical, INC. | $44.40 | 2019-2023 | Paragard T 380a |
| Avion Pharmaceuticals | $40.49 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $29.92 | 2019 | |
| Allergan, INC. | $28.98 | 2019 | |
| Lupin INC. | $26.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.78 | 2022 | |
| Organon LLC | $15.27 | 2023 | Nexplanon |
| Millicent US INC | $12.81 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Darvish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.